Postbiotic Innovation — Beyond Probiotics

• October 27, 2025
• SporeGen

A Market-Ready Anti-Viral Nasal Spray

SporeGen Proud to Sponsor CHRO 2026 in Vietnam

• September 30, 2025
• SporeGen

SporeGen Proud to Sponsor the 23rd International CHRO Workshop in Ho Chi Minh City, Vietnam

Revolutionizing C. difficile Prevention

• September 15, 2025
• SporeGen
• Latest News

A first-of-its-kind microbiome-based platform for C. difficile relapse prevention - proven, patent-protected, and ready for food & pharma partners.

SporeGen Contributes to Groundbreaking Research on the use of Bacillus Postbiotics for Respiratory Infections

• April 16, 2025
• SporeGen

European Patent Office to Grant SporeGen’s Patent Application for THY-X-CISE® Technology

• September 25, 2023
• SporeGen